Sign in

What researchers published on Idiopathic pulmonary fibrosis

10,460 papers, newest first.

Showing 180 of 10,460

  • Long-Term Prognosis and Transition Period until Progression in Fibrotic Hypersensitivity Pneumonitis.Respiration; international review of thoracic diseases
  • ReviewStem cell-derived EVs in the treatment of pulmonary fibrosis: from mechanistic insights to clinical-grade manufacturing and nebulized delivery.Expert review of respiratory medicine
  • Indoor Air Quality Management for Patients with COPD and IPF: Practical Recommendations Based on Current Standards and Evidence.Tuberculosis and respiratory diseases
  • A Mucin-5B variant associated with idiopathic pulmonary fibrosis may prolong survival in the general population.The Journal of clinical investigation
  • Association of idiopathic pulmonary fibrosis with TG/HDL-C and TC/HDL-C: a retrospective cohort study.BMC pulmonary medicine
  • LitGene: an interpretable transformer model integrating text and ontology for gene representation learning.Nature communications
  • A multi-targeted, barrier-penetrating inhalable nanoplatform for simultaneous immunomodulation and antifibrotic therapy in idiopathic pulmonary fibrosis.Materials today. Bio
  • ReviewDifferentiation arrest of transitional alveolar epithelial cells drives pulmonary fibrosis.Cell communication and signaling : CCS
  • Alive and on Initial Antifibrotic Treatment: Real-World Treatment Durability in Idiopathic and Progressive Pulmonary Fibrosis.Journal of clinical medicine
  • ReviewPulmonary Fibroblast Heterogeneity and Functional Remodeling in Idiopathic Pulmonary Fibrosis: State Persistence and Reversibility.International journal of molecular sciences
  • Vitamin K3 (Menadione) Targets TBK1 to Enhance the Efficacy of Pirfenidone in a Mouse Model of Bleomycin-Induced Pulmonary Fibrosis.International journal of molecular sciences
  • ReviewPCSK6 in Pathophysiology and Its Potential Involvement in Pulmonary Fibrosis.Molecules (Basel, Switzerland)
  • Single-Cell Transcriptomic Analysis Identifies a Translation/RBP-Related Fibroblast Signature for Drug Repurposing in Idiopathic Pulmonary Fibrosis.International journal of molecular sciences
  • Quality of Spirometry Maneuvers in Interstitial Lung Disease Patients in a Tertiary Facility.Journal of clinical medicine
  • ReviewSelective Immune Clearance and Lung Repair in Pulmonary Fibrosis.Biology
  • The role of 18F-FDG PET-CT in predicting progressive pulmonary fibrosis in idiopathic inflammatory myopathy associated interstitial lung disease.Frontiers in immunology
  • ReviewIdiopathic pulmonary fibrosis: Five trials to watch.Med (New York, N.Y.)
  • The Burden of Chronic Cough in Patients With Interstitial Lung Disease: a US Survey-Based Analysis of Its Effects on Daily Life and Emotional and Social Well-Being.Chest
  • Transcriptomic Signature-Guided EGFP Labeling of Alveolar Epithelial Cells via RNA Sensing in Mouse Lungs In Vivo and Human Idiopathic Pulmonary Fibrosis Lung Slices Ex Vivo.Bio-protocol
  • Lung-Tailored Pyrrolo-pyrimidine DDR Inhibitors Designed for Optimized Local Delivery.Journal of medicinal chemistry
  • ReviewObstructive Sleep Apnea, Ferroptosis, and Idiopathic Pulmonary Fibrosis: A Potential Second-Hit Mechanism Linking Intermittent Hypoxia to Fibrotic Progression.Respiratory medicine
  • Integrated Multi-Omics Identifies SLIT2 as a Regulator of Senescence-Associated Fibroblast Remodeling in Idiopathic Pulmonary Fibrosis.Inflammation
  • Discovery of YKS-34, a Highly Selective PDE4B Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis.Journal of medicinal chemistry
  • Meta-analysisEffects of different durations of exercise-based pulmonary rehabilitation intervention in patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis.Medicine
  • ReviewInhalable nanodelivery strategies for overcoming the pathological cascade of idiopathic pulmonary fibrosis.International journal of pharmaceutics
  • RNA-binding proteins as emerging regulators in interstitial lung diseases.American journal of respiratory cell and molecular biology
  • Extracellular vesicles presenting "don't eat me" signal limit the efferocytic capacity in lung fibrosis.Proceedings of the National Academy of Sciences of the United States of America
  • Selective ORgan-targeting lipid nanoparticles deliver SMAD7 mRNA to fibrotic lungs and attenuate pulmonary fibrosis.Journal of controlled release : official journal of the Controlled Release Society
  • Time is lung? Quantitative CT and earlier detection of progressive pulmonary fibrosis.Annals of the American Thoracic Society
  • Tacrolimus ameliorates pulmonary hypertension associated with pulmonary fibrosis via modulation of vascular remodeling.Frontiers in pharmacology
  • ReviewLactate-associated fibroblast-macrophage signaling in idiopathic pulmonary fibrosis: evidence boundaries and immunopharmacological opportunities.Frontiers in pharmacology
  • Clinical and prognostic characteristics of concurrent small cell lung cancer in patients with idiopathic pulmonary fibrosis: a retrospective study.Journal of thoracic disease
  • ReviewHypersensitivity Pneumonitis: Clinical Paradigm Evolution, Immune-Driven Mechanisms, and Fibrotic Progression.Journal of immunology research
  • Jinshui Huanxian Formula Combined with Exercise Rehabilitation Improves Skeletal Muscle Mitochondrial Damage in Treatment of Pulmonary Fibrosis by AMPK/mTOR/HIF-1 Pathway.Chinese journal of integrative medicine
  • Weight Loss, FVC Decline, and Composite Physiologic Index as Complementary Prognostic Indicators in Idiopathic Pulmonary Fibrosis over the Disease Course: Time-Updated and Landmark Analysis.Archivos de bronconeumologia
  • Large-scale plasma proteomics identifies proteins and pathways associated with incident interstitial lung disease.Frontiers in immunology
  • CXCL12: a key gene in IPF-COPD pathogenesis and its therapeutic potential.Journal of translational medicine
  • Discovering Biomarkers for Idiopathic Pulmonary Fibrosis by Correlating Serum Extracellular Vesicle Proteins With Clinical Data.Proteomics. Clinical applications
  • Alveolar Type II Cell-derived MMP1high basal cells promote destructive microcysts in idiopathic pulmonary fibrosis.JCI insight
  • Integrating multi-omics and machine learning to reveal IL1R2-driven macrophage-fibroblast spatial interactions in polycyclic aromatic hydrocarbon-induced pulmonary fibrosis.Frontiers in immunology
  • Lifetime Endogenous Estrogen Exposure Predicts Idiopathic Pulmonary Fibrosis Risk in Postmenopausal Women Based on a Nationwide Population Study.Journal of Korean medical science
  • Tocilizumab in refractory anti-synthetase syndrome-associated interstitial lung disease:a phenotype-stratified cohort study.Respiratory research
  • Macrophage-targeted GAS6 siRNA delivery by a multifunctional mannan-peptide nanocarrier attenuates pulmonary fibrosis progression.Journal of controlled release : official journal of the Controlled Release Society
  • [Unfavorable prognosis of pathogenic variants in the telomerase complex in cases of familial pulmonary fibrosis].Revue des maladies respiratoires
  • Exogenous tryptophan aggravates experimental lung fibrosis through activation of AKT-mTORC1 pathway.PloS one
  • Progressive pulmonary fibrosis in fibrotic interstitial lung disease: a Danish cohort study.ERJ open research
  • Local and systemic SP-D in IPF and SARD-ILD.BMC pulmonary medicine
  • ReviewCombined Pulmonary Fibrosis and Emphysema: Current Status and Future Perspective.The clinical respiratory journal
  • 6-min walk test reveals early physiological impairment in fibrotic interstitial lung diseases.ERJ open research
  • Integrative Multi-omics and machine learning analysis of sphingolipid-associated molecular stratification identifies diagnostic and prognostic signatures in idiopathic pulmonary fibrosis.Orphanet journal of rare diseases
  • A plain language review of the TETON-1 and TETON-2 studies: inhaled treprostinil (Tyvaso) in idiopathic pulmonary fibrosis.Expert review of respiratory medicine
  • Deep learning-based quantification of CT changes after 1 year of pirfenidone treatment as a prognostic marker in idiopathic pulmonary fibrosis.Insights into imaging
  • Review[The role of immune checkpoints in idiopathic pulmonary fibrosis: An emerging therapeutic paradigm].Revue des maladies respiratoires
  • Integrative network toxicology and machine learning reveal the potential role of 5-hydroxymethylfurfural in exacerbating pulmonary fibrosis.PloS one
  • The prognostic value of erythrocyte sedimentation rate in all-cause mortality of patients with idiopathic pulmonary fibrosis: Based on inpatient hospital records.Therapeutic advances in respiratory disease
  • ReviewTreprostinil: Mechanism of Action, Clinical, and Translational Science.Clinical and translational science
  • Effectiveness of home-based pulmonary rehabilitation in patients with interstitial lung disease: a systematic review and meta-analysis.BMJ open respiratory research
  • Targeting ACKR1+ Endothelial Cells Attenuates Pulmonary Fibrosis by Halting Monocytes Infiltration/Polarization and Endothelial-to-Mesenchymal Transition.Pharmacological research
  • ReviewPathological regulatory roles of lysine acylation modifications in idiopathic pulmonary fibrosis (Review).Molecular medicine reports
  • Integrative network toxicology and pharmacology reveal that kaempferol alleviates BaP-triggered pulmonary fibrosis via suppressing Ras/COX-2-dependent cellular senescence.Frontiers in pharmacology
  • Soluble macrophage-mannose receptor, CD206 (sCD206): A new potential biomarker for idiopathic pulmonary fibrosis.Immunobiology
  • Serum KL-6 Levels at Acute Exacerbation in Patients With Interstitial Lung Disease.In vivo (Athens, Greece)
  • Metabolomic Profiles Predict the Risk of Idiopathic Pulmonary Fibrosis.Phenomics (Cham, Switzerland)
  • ReviewCardiovascular complications in idiopathic pulmonary fibrosis and the emerging concept of the heart-lung fibrotic axis: a narrative review.Frontiers in medicine
  • IPF-RAG: temporal-aware retrieval-augmented generation for idiopathic pulmonary fibrosis care.Frontiers in digital health
  • Survival and immunomodulatory therapy in autoimmune disease-associated progressive pulmonary fibrosis: a multicenter registry (NEREA).Rheumatology (Oxford, England)
  • Tectochrysin alleviates idiopathic pulmonary fibrosis via inhibiting PI3K/AKT/mTOR signaling pathway by targeting PI3K p85.Pulmonary pharmacology & therapeutics
  • Distinct BAL cytokine signatures define immunopathological endotypes in interstitial lung disease.Frontiers in physiology
  • PRDM16 attenuates pulmonary fibrosis through NuRD-mediated epigenetic remodeling in lung fibroblasts.Science China. Life sciences
  • Real-World Management and Outcomes of Probable and Indeterminate UIP Patterns on HRCT: A Retrospective Cohort Study and Implications for the 2022 IPF Guideline.Journal of clinical medicine
  • Association of the Charlson Comorbidity Index and Age-Adjusted Charlson Comorbidity Index with Clinical Course and Mortality in Patients with Idiopathic Pulmonary Fibrosis.Biomedicines
  • The Impact of Idiopathic Pulmonary Fibrosis on the Incidence and Severity of Radiation Pneumonitis in Non-Small Cell Lung Cancer Patients Following Radiotherapy.Biomedicines
  • ReviewUpdates on the Translational Value of Idiopathic Pulmonary Fibrosis Models Across Species: Deeper Insights Through Comparative Pathology.Biomolecules
  • ReviewThe Shared Pathological Niche in Pulmonary Fibrosis: From Aberrant Epithelial Repair to ECM Remodeling.Biomedicines
  • Prevalence and prognostic significance of obstructive sleep apnea in patients with idiopathic pulmonary fibrosis: A prospective cohort study.Annals of thoracic medicine
  • Shared Enrichment of the MUC5B Variant rs35705950 in Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis: Evidence from a Russian Cohort.Diagnostics (Basel, Switzerland)
  • Meta-analysisPerioperative Antifibrotic Treatment and Early Postoperative Outcomes in Patients With Idiopathic Pulmonary Fibrosis Undergoing Lung Cancer Surgery: A Systematic Review and Meta-Analysis.Thoracic cancer
  • Meta-analysisEfficacy and Safety of Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.Advances in respiratory medicine
  • Correction: Comprehensive analysis of neutrophil extracellular traps-associated inflammatory genes for patients with idiopathic pulmonary fibrosis.Molecular genetics and genomics : MGG
  • Hyperpolarized 129Xe MRI membrane uptake associates with lung function changes in patients with idiopathic pulmonary fibrosis initiating antifibrotic therapy.American journal of respiratory and critical care medicine
  • TOMM5-glycolysis-Mlxipl axis: A novel mechanistic insight into idiopathic pulmonary fibrosis.Biochimica et biophysica acta. Molecular basis of disease
  • Emergency granulopoiesis is associated with intermittent hypoxemia in idiopathic pulmonary fibrosis.American journal of respiratory and critical care medicine
  • Bridging the GAP: Prognostic stratification by longitudinal FVC changes in IPF.Journal of the Chinese Medical Association : JCMA
  • ReviewThe Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio for Mortality in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.Cureus
  • ReviewTherapeutic advances in pulmonary fibrosis.Therapeutic advances in respiratory disease
  • Nailfold videocapillaroscopy as a diagnostic clue in interstitial lung disease: differentiating idiopathic from autoimmune patterns in a Caucasian cohort.Reumatismo
  • PreprintSobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis.bioRxiv : the preprint server for biology
  • Effect of exportin-1 inhibitors on profibrotic responses in human lung fibroblasts.Biochemical and biophysical research communications
  • Institutional patterns in diagnosis and antifibrotic-era treatment uptake for IPF and PPF across U.S. centers.PloS one
  • Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variants.The European respiratory journal
  • Predicting progressive pulmonary fibrosis in idiopathic inflammatory myopathy-associated interstitial lung disease: A machine learning approach integrating quantitative CT and clinical features.Respiratory medicine
  • Lung Transplantation for Interstitial Lung Disease: A Northern Ireland Cohort Study.Pulmonary therapy
  • Pulmonary diffusion capacity to select patients for echocardiographic evaluation of pulmonary hypertension in interstitial lung disease: Impact of interstitial lung disease phenotype.Respiratory investigation
  • ReviewSpatiotemporal Immune-Fibroblast Crosstalk in Pulmonary Fibrosis: From Failed Repair to Fibrotic Niche Formation.International journal of biological sciences
  • Observational studyInterstitial Lung Diseases treatment prescription practices among pulmonologists in India: A prospective multicentre observational study (India-ILD care study).PloS one
  • ReviewA narrative review of stem cell-based therapy for fibrosing interstitial lung diseases: clinical evidence and translational perspectives.Frontiers in pharmacology
  • Ism1 deficiency in mice exacerbates bleomycin-induced pulmonary fibrosis with enhanced cellular senescence and delayed fibrosis resolution.hLife
  • Case reportNerandomilast treatment improves a case of progressive pulmonary fibrosis combined with severe plaque psoriasis: A case report from a clinical trial.Therapeutic advances in respiratory disease
  • Systematic reviewPhase 3 Antifibrotic-Directed Therapy Outcomes in Idiopathic Pulmonary Fibrosis: Beyond FVC Decline.Lung
  • Cellular Senescence Dysregulates Antiviral Interferon Responses in Idiopathic Pulmonary Fibrosis.Aging cell
  • Utility of Bronchoalveolar Lavage Fluid Cellular Composition in the Differential Diagnosis of Idiopathic Pulmonary Fibrosis: a preliminary study.Malawi medical journal : the journal of Medical Association of Malawi
  • A novel inhalable tanshinone IIA lipid nanocrystal formulation for the enhanced treatment of idiopathic pulmonary fibrosis.Journal of nanobiotechnology
  • Deleted in lymphocytic leukemia 2 contributes to lung fibroblast activation and pulmonary fibrosis by interacting with and triggering focal adhesion kinase phosphorylation.Respiratory research
  • Reply: Comparative Clinical Outcomes of Nintedanib and Pirfenidone in Idiopathic Pulmonary Fibrosis: A Five-Year Real-Life Study.Thoracic research and practice
  • Translation, Cultural Adaptation, and Validation of the Turkish Version of the St George's Respiratory Questionnaire for Idiopathic Pulmonary Fibrosis (SGRQ-I).Thoracic research and practice
  • ReviewMUC5B/TGF-β/KL-6 Signaling in Idiopathic Pulmonary Fibrosis: Genetic Susceptibility to Profibrotic Progression and Clinical Perspectives.Lung
  • Pulmonary hypertension optimal screening in interstitial lung disease (PHOS-ILD): a scoring system for the detection of pulmonary hypertension in patients with interstitial lung disease.Frontiers in medicine
  • Automated quantitative analysis can support the identification of progressive pulmonary fibrosis in fibrotic interstitial lung disease.BMJ open respiratory research
  • ReviewSingle‑cell and spatial transcriptomics in chronic lung disease: cellular heterogeneity and molecular mechanisms in IPF and COPD.Respiratory research
  • Obesity and the risk of idiopathic pulmonary fibrosis: a nationwide population-based study.BMJ open respiratory research
  • Case reportRheumatoid arthritis-associated interstitial lung disease presenting before articular manifestations: A case report.Respiratory medicine case reports
  • Observational studyIndirect Echocardiographic Signs of Increased Right-sided Afterload in Progressive Pulmonary Fibrosis: Insights from a Multicentre Italian Study.Lung
  • The PIEZO1/CISD1/IP3R Mechanotransduction Axis Drives Macrophage Mitochondrial Dysfunction and Inflammatory Activation in Pulmonary Fibrosis.MedComm
  • Association between Telomere Length and Idiopathic Pulmonary Fibrosis: A Case-Control Study.Tanaffos
  • Integrated UPLC-Q-Orbitrap-MS/MS, network pharmacology, and in vivo evaluation reveal bioactive constituents and mechanisms of Bushen Tongluo Decoction against idiopathic pulmonary fibrosis.Journal of pharmaceutical and biomedical analysis
  • Dynamic tensile conditioning of mesenchymal stem cell-laden auxetic scaffolds for enhanced YAP-dependent miR-30 enrichment in extracellular vesicles for pulmonary fibrosis therapy.Biomaterials
  • ReviewSingle-cell multi-omics in IPF and COPD: from atlas to impact.The European respiratory journal
  • Connective tissue disease-associated interstitial lung disease: immune profiling and correlation of immune cells with pulmonary function in SSc-ILD.Annals of medicine
  • Case reportSpontaneous pneumomediastinum and subcutaneous emphysema during acute exacerbation of idiopathic pulmonary fibrosis: a case report.Respiratory medicine case reports
  • Absolute and lung volume-normalized deep learning-derived pulmonary vascular measures in idiopathic pulmonary fibrosis: distinct clinical associations and the role of lung volume in prognosis.Frontiers in medicine
  • Tofacitinib in rheumatoid arthritis-associated interstitial lung disease: immunomodulation and antifibrotic therapy as complementary strategies?Respiratory medicine
  • Quantitative CT in the real-world evaluation of progressive pulmonary fibrosis; the REVISE PPF multicentre observational study.Annals of the American Thoracic Society
  • Case reportNintedanib-induced Glomerular Microangiopathy after Long-term Nintedanib Administration Presenting with Nephrotic Syndrome.Internal medicine (Tokyo, Japan)
  • Yoga effect on quality of life study among patients with idiopathic pulmonary fibrosis (YES-IPF).Respiratory medicine
  • Nintedanib in progressive fibrosing hypersensitivity pneumonitis: Real-world effects on lung function and survival.Therapeutic advances in respiratory disease
  • ReviewInterstitial lung disease as the initial manifestation of systemic autoimmune disease: a narrative review of autoantibodies, biomarkers, prognosis, and management.Clinical and experimental rheumatology
  • ReviewMMP-7 as a non-invasive biomarker in interstitial lung diseases and other chronic respiratory diseases: a narrative review.Frontiers in medicine
  • Case reportInterstitial lung disease exacerbations following initiation of nerandomilast: A case series.Respiratory medicine case reports
  • ReviewTranscriptional factor KLF9 in pulmonary fibrosis: from molecular mechanisms to precision intervention-a narrative review.Journal of thoracic disease
  • Protocol and rationale for a randomised, double-blind, placebo-controlled phase 3 trial of admilparant (BMS-986278), an oral lysophosphatidic acid receptor 1 antagonist, in patients with idiopathic pulmonary fibrosis: ALOFT-IPF.BMJ open respiratory research
  • Nedd4L-mediated stabilization of morphogenetic protein receptor 2 in lung fibroblasts confers protection against pulmonary fibrosis.Signal transduction and targeted therapy
  • Nomogram models integrating multiregion radiomics, quantitative computed tomography, and clinical indicators for distinguishing connective tissue disease-associated interstitial lung disease from idiopathic pulmonary fibrosis and improving the prediction of gender-age-physiology stage.Quantitative imaging in medicine and surgery
  • Construction of a soluble mediator landscape and analysis of its clinical diagnostic potential in idiopathic pulmonary fibrosis.Computational biology and chemistry
  • Integrated transcriptomic and experimental analyses identify SRPK1/SRSF1 as a therapeutically relevant splicing regulatory axis in pulmonary fibrosis.Cellular signalling
  • Serial multidomain six-minute walk assessment for dynamic risk prediction in idiopathic pulmonary fibrosis.American journal of respiratory and critical care medicine
  • ReviewInhalation therapies in interstitial lung diseases.Expert opinion on drug delivery
  • Interstitial lung disease with associated severe pulmonary hypertension is rarely idiopathic by clinical or pathologic measures.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • Association of CYFRA 21-1 with quantitative CT-defined fibrotic progression in idiopathic pulmonary fibrosis.BMC pulmonary medicine
  • Prevalence and patterns of inhalational exposures in patients with interstitial lung diseases: a cross-sectional study.Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace
  • [Treatment of pulmonary fibrosis: Beginning of a new era].Pneumologie (Stuttgart, Germany)
  • Parasite-Derived IL-33 Inhibitors Prevent Bleomycin-Induced Lung Fibrosis.European journal of immunology
  • Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.The New England journal of medicine
  • Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.The New England journal of medicine
  • Trial resultDesign Paper: The Short- and Long-term Effects of Inspiratory Muscle Training in Patients with Idiopathic Pulmonary Fibrosis-A Multicenter Randomized Controlled Trial (the Breathe IPF Trial).JMA journal
  • Analysis of clinical characteristics and risk factors of progressive pulmonary fibrosis associated with systemic sclerosis.Medicina clinica
  • Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis. Reply.The New England journal of medicine
  • Use of lung ultrasound surface wave elastography in patients with interstitial lung disease.BMJ open respiratory research
  • Inhibition of the MER tyrosine kinase ameliorates pulmonary fibrosis by suppressing macrophage M2 polarisation and osteopontin signalling.British journal of pharmacology
  • Quantitative Chest CT-derived Fibrosis and Vascular Remodeling and Acute Exacerbation Risk in Mild Idiopathic Pulmonary Fibrosis.Radiology
  • Almost There: Approaching a Pragmatic Definition of Combined Pulmonary Fibrosis and Emphysema.Respirology (Carlton, Vic.)
  • Nebulized inhalation of exosomes from human umbilical cord mesenchymal stem cells alleviates bleomycin-induced pulmonary fibrosis through tsRNA cargos.Tissue & cell
  • Integrative multiomics and machine learning identify uridine as a candidate modulator of MMP7-mediated immune cell infiltration in pulmonary fibrosis.Journal of advanced research
  • Clinical characteristics associated with pulmonary function decline despite sustained nintedanib therapy in systemic autoimmune rheumatic disease-related progressive pulmonary fibrosis.Modern rheumatology
  • Targeting the CD4+ effector memory T cells re-expressing CD45RA suppressor galectin-7: a multi-omics-guided therapeutic strategy for idiopathic pulmonary fibrosis.Molecular biomedicine
  • Nerandomilast is Associated With Altered Alveolar Epithelial Cell State Dynamics While Attenuating Fibrotic Remodeling in Pulmonary Fibrosis.Genes to cells : devoted to molecular & cellular mechanisms
  • Pulmonary fibrosis through patients' eyes: an interpretative phenomenological analysis of illness perceptions and acceptance.Therapeutic advances in respiratory disease
  • ReviewManagement of Pulmonary Hypertension in Interstitial Lung Disease Without Access to Inhaled Treprostinil: A Case Series from a Resource-Limited Setting.The American journal of the medical sciences
  • The Ethics of Lung Cancer Education for Pulmonary Fibrosis Patients: Addressing Diagnostic Overshadowing and Cancer Risk.Journal of cancer education : the official journal of the American Association for Cancer Education
  • Research on the role and mechanism of SLC7A5 in idiopathic pulmonary fibrosis.Molecular medicine reports
  • PreprintMechanosignaling promotes macrophage apoptosis resistance in pulmonary fibrosis via metabolic reprogramming.bioRxiv : the preprint server for biology
  • Neutrophils and CSF1 promote the expansion of monocyte-derived alveolar macrophages in progressive pulmonary fibrosis.American journal of physiology. Lung cellular and molecular physiology
  • Smoking exposures and mortality risk in individuals with idiopathic pulmonary fibrosis: a UK Biobank cohort study.Frontiers in public health
  • ReviewAdvances in prognostic assessment of idiopathic pulmonary fibrosis: From clinical-physiological parameters and molecular biomarkers to multimodal models.Respiratory medicine
  • Multi-omics integration reveals the CTSK-cholesterol metabolic axis and the cholesterol-RORA/LDLR paracrine axis in SPP1+ macrophages as mediators of 6PPD-quinone-induced idiopathic pulmonary fibrosis.Environmental pollution (Barking, Essex : 1987)
  • End of rarity: the evolving burden of interstitial lung diseases in England - trends from a national population-based cohort study.Thorax
  • ReviewThe impact of macrophage metabolism on idiopathic pulmonary fibrosis development and treatment prospectives.Frontiers in immunology
  • PreprintLymphatic ERG Governs Junctional Plasticity and Fluid Clearance via an EDNRB Signaling Axis in Pulmonary Fibrosis.bioRxiv : the preprint server for biology
  • Case reportNintedanib-Associated Generalized Body Swelling in a Patient With Idiopathic Pulmonary Fibrosis: A Case Report.Cureus
  • Anxiety and depression symptoms, coping strategies, and appraisal of living with idiopathic pulmonary fibrosis: implications for psychological support.ERJ open research
  • Fibroblast proliferative capacity predicts prognosis in idiopathic pulmonary fibrosis and identifies PITX1 as a growth-associated gene.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
  • Targeting senescence-associated fibrotic signatures identifies syringin as an effective modulator of the ATR/CHK1-p53 axis in idiopathic pulmonary fibrosis.Chinese journal of natural medicines
  • ReviewEndoplasmic reticulum stress and maladaptive repair in fibrotic interstitial lung diseases: A human-evidence-based narrative review.Therapeutic advances in respiratory disease
  • Pulse versus Nonpulse Corticosteroid Therapy in Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized Clinical Trial (SAFER).American journal of respiratory and critical care medicine
  • Peripheral immune checkpoint gene expression as diagnostic biomarkers in idiopathic pulmonary fibrosis.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
  • Efficacy and safety of extended-release oral opioid for cough in idiopathic pulmonary fibrosis: A systematic review and meta-analysis of randomized controlled trials.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
  • Postoperative acute exacerbations in patients with idiopathic pulmonary fibrosis undergoing lung cancer surgery.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
  • Reflections of upper extremity performance in idiopathic pulmonary fibrosis on exercise capacity, clinical status, and quality of life.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
  • Folate metabolism-related gene signature reveals prognostic and immunological characteristics in idiopathic pulmonary fibrosis.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
  • Trajectories of progressive pulmonary fibrosis and outcomes in connective tissue disease associated interstitial lung disease (CTD-ILD).Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
  • Quantitative Computed Tomography in Progressive Pulmonary Fibrosis: Data from a Sub-Study of the Double Blind, Randomized, Placebo-controlled INBUILD Trial.American journal of respiratory and critical care medicine